475 Avenue Louise1050 Brussels (Belgium)+32 (0) 22 457 105
Rbla. Catalunya 60 Pral. 2ª08007 Barcelona (Spain)+34 932 721 320
Linkedin
info@careventures.eu
Centogene announces publication establishing Lyso-Gb1 as a predictive biomarker for Gaucher disease patients
Centogene Biodatabank reveals unique genetic variants in world’s largest Niemann-Pick Type C1 disease cohort
A project co-funded by Corus finds a new therapeutic alternative for HER2+ breast cancer
Centogene launches new CentoGenome®, world’s most comprehensive whole genome sequencing solution for diagnosis of rare and neurodegenerative diseases
Corus’ presence at the Dental Tribune’s IDS 2023
Centogene is partnering with IQVIA to improve health outcomes for rare disease patients
Corus expands into the UK with the integration of Byrnes Dental Laboratory
Corus grows in Spain with the acquisition of two laboratories in Seville and Madrid
Centogene reaches 12,500 patient milestone in world’s largest observational study on Parkinson’s disease genetics